Impact of pain and adverse health outcomes on long-term US testicular cancer survivors

• Published in: JNCI : Journal of the National Cancer Institute Vol. 116; no. 3; pp. 455 - 467
• Main Authors: Dinh, Jr, Paul C, Monahan, Patrick O, Fosså, Sophie D, Sesso, Howard D, Feldman, Darren R, Dolan, M Eileen, Nevel, Kathryn, Kincaid, John, Vaughn, David J, Martin, Neil E, Sanchez, Victoria A, Einhorn, Lawrence H, Frisina, Robert, Fung, Chunkit, Kroenke, Kurt, Travis, Lois B
• Format: Journal Article
• Language: English
• Published: United States 07.03.2024
• Subjects: Adult; Antineoplastic Agents - therapeutic use; Diabetes Mellitus - drug therapy; Diabetes Mellitus - epidemiology; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neuralgia - drug therapy; Obesity; Outcome Assessment, Health Care; Patient Reported Outcome Measures; Quality of Life; Survivors; Testicular Neoplasms - complications; Testicular Neoplasms - drug therapy

No study has quantified the impact of pain and other adverse health outcomes on global physical and mental health in long-term US testicular cancer survivors or evaluated patient-reported functional impairment due to pain. Testicular cancer survivors given cisplatin-based chemotherapy completed vali...